Madhukar H. Trivedi, M.D.
Madhukar H. Trivedi, M.D., attended medical school at the Maharaja Sayajirao University of Baroda in India and served his psychiatry residency at Henry Ford Health System in Detroit. Dr. Trivedi is the principal investigator in the Establishing Moderators/Biomarkers of Antidepressant Response for Clinical Care (EMBARC) trial, a multicenter study sponsored by the National Institute of Mental Health that is testing the clinical use of biomarkers in depression treatment.
Biomarkers and the Future of Treatment for Depression
There is currently no way to determine which antidepressant will work best for a given patient, which means that many people continue to suffer while their doctors try a series of medications. Many researchers have now focused their efforts on developing biomarkers for depression—tests for aspects of a patient’s physiology that can predict a clinical outcome. In the future, doctors may be able to screen patients to determine which treatment options will work for them, reducing the time a patient must continue to live with the effects of depression.